Advertisement
Resource
Transparent Process
Open Access

Identification of biomarkers, pathways, and therapeutic targets for EGFR–TKI resistance in NSCLC

Leilei Zhu, Shanshan Gao, Xianya Zhao, Ying Wang  Correspondence email
Published 10 October 2023. DOI: 10.26508/lsa.202302110

Article Information

vol. 6 no. 12 e202302110
DOI 
https://doi.org/10.26508/lsa.202302110
PubMed 
37816585
Published By 
Life Science Alliance
Online ISSN 
2575-1077
History 
  • Received April 22, 2023
  • Revision received September 27, 2023
  • Accepted September 28, 2023
  • Published online October 10, 2023.
Copyright & Usage 
© 2023 Zhu et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).

Author Information

  1. Leilei Zhu1, Conceptualization, Resources, Writing—original draft,
  2. Shanshan Gao1, Data curation, Software, Formal analysis,
  3. Xianya Zhao1, Software, Formal analysis, Supervision, Validation, Visualization, Methodology and
  4. Ying Wang2, Conceptualization, Resources, Project administration, Writing—review and editing⇑
  1. 1Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University; Anhui Public Health Clinical Center, Hefei, China
  2. 2Department of Respiratory Medicine, Anhui Provincial Children's Hospital (Children's Hospital of Fudan University Anhui Hospital), Hefei, China
  1. Correspondence: etyywangying{at}163.com
View Full Text
Back to top
Download PDF
Email Article
Citation Tools
EGFR TKI resistance in NSCLC using bioinformatics
Leilei Zhu, Shanshan Gao, Xianya Zhao, Ying Wang
Life Science Alliance Oct 2023, 6 (12) e202302110; DOI: 10.26508/lsa.202302110
Twitter logo Facebook logo Mendeley logo
Issue Cover

In this Issue

Volume 6, No. 12
December 2023
Advertisement

Jump to section

Subjects

Related Articles

  • No related articles found.

Cited By...

  • No citing articles found.

More in this TOC Section

Similar Articles